Shujie He

693 citations
17 papers · 539 indexed · h-index 9
Topics
Renal and related cancers (4 papers)Renal cell carcinoma treatment (3 papers)Melanoma and MAPK Pathways (3 papers)
Partner nations
New ZealandChinaCanada

In The Last Decade

Shujie He

16 papers receiving 532 citations

Peers

Shujie He
Comparison fields: 5 of 67
  • Molecular Biology 428
  • Oncology 109
  • Cancer Research 87
  • Pulmonary and Respiratory Medicine 86
  • Genetics 64
Replace Tetsuroh Saitoh with:
Tetsuroh Saitoh Japan
Mirko Müller Germany
Akio Iwai Japan
María Giselle Peters Argentina
Olivia Alder United Kingdom
Costanza Ballarò Italy
Nicole Forster United States
Tian V. Tian Spain
Asha Padar United States
Bálint Péterfia Hungary
Shujie He relative to Tetsuroh Saitoh Japan Tetsuroh Saitoh's profile →
Citations per field
00.5×2.7×
Tetsuroh Saitoh · 1×
Citations per year

Countries citing papers authored by Shujie He

Since Specialization
Citations

This map shows the geographic impact of Shujie He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shujie He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shujie He more than expected).

Fields of papers citing papers by Shujie He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shujie He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shujie He. The network helps show where Shujie He may publish in the future.

Co-authorship network of co-authors of Shujie He

This figure shows the co-authorship network connecting the top 25 collaborators of Shujie He. A scholar is included among the top collaborators of Shujie He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shujie He. Shujie He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
#WorkIndexed citations
1 1
2 0
3 3
4 2
5 10
6 15
7 1
8 28
9
Effects of Material Parameters on Deliveries of Seven Harmful Components in Cigarette Smoke
1
10 18
11 67
12 8
13 227
14 44
15 32
16 79
17
ACTIVATION OF CREB INDUCED BY X RAYS AND ITS RELATIONSHIP WITH cAMP SIGNAL PATHWAY
3

About Shujie He

Shujie He is a scholar working on Cancer Research, Oncology and Molecular Biology, having authored 17 papers that have together received 539 indexed citations. Recurring topics across this work include Renal and related cancers (4 papers), Renal cell carcinoma treatment (3 papers) and Melanoma and MAPK Pathways (3 papers). The work is most often cited by research in Molecular Biology (428 citations), Cancer Research (87 citations) and Oncology (109 citations). Shujie He has collaborated with scholars based in New Zealand, China and Canada. Frequent co-authors include Michael R. Eccles, Ewan J.D. Robson, Bruce C. Baguley, Lynn Slobbe, Antony W. Braithwaite, Chaoming Zhou, Michael Legge, Michelle C. French, Rajiv Kumar and Aaron Jeffs. Their work appears in journals such as Nature reviews. Cancer, PLoS ONE and Oncogene.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026